SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $244,000 | -5.4% | 3,259 | -1.5% | 0.04% | +12.5% |
| Q1 2022 | $258,000 | -44.8% | 3,309 | -36.2% | 0.03% | -42.9% |
| Q4 2021 | $467,000 | -1.7% | 5,184 | +1.0% | 0.06% | -11.1% |
| Q3 2021 | $475,000 | +18.5% | 5,132 | -0.5% | 0.06% | +14.5% |
| Q2 2021 | $401,000 | +24.9% | 5,159 | +19.6% | 0.06% | +17.0% |
| Q1 2021 | $321,000 | -3.0% | 4,312 | +122.0% | 0.05% | -11.3% |
| Q4 2020 | $331,000 | +25.9% | 1,942 | +3.8% | 0.05% | +6.0% |
| Q3 2020 | $263,000 | -6.7% | 1,871 | +6.4% | 0.05% | -16.7% |
| Q2 2020 | $282,000 | – | 1,758 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |